Drug intelligence / Profile preview

miR-10a mimic

Development stage
Preclinical
Lead developer
UT Health San Antonio
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Oral, Subcutaneous, Intravenous, Intraperitoneal, Intranasal, Inhalation, Parenteral
01

Overview

miR-10a mimic is a synthetic microRNA designed to replicate the function of endogenous miR-10a, which acts as a tumor suppressor in various cancers, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The mimic functions by binding to the 3' untranslated region (UTR) of target mRNAs, leading to their degradation or translational inhibition. A primary target of miR-10a is the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), a key regulator of the PI3K/AKT/mTOR signaling pathway that drives cell proliferation and survival. By restoring miR-10a levels, the mimic reduces PI3K expression, thereby decreasing cell viability and potentially sensitizing tumor cells to other therapies.

Other names
microRNA-10a mimicmicroRNA10a mimicmicroRNA 10a mimichsa-miR-10a mimichsa-miR10a mimichsa-miR 10a mimic
02

Targets

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha messenger RNA (PIK3CA mRNA)

Beyond the preview

Go deeper on miR-10a mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-10a mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call